Page last updated: 2024-11-04

sulfasalazine and Lymphangiectasis

sulfasalazine has been researched along with Lymphangiectasis in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Lymphangiectasis: A transient dilatation of the lymphatic vessels.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kovi, J1
Duong, HD1
Hoang, CT1

Other Studies

1 other study available for sulfasalazine and Lymphangiectasis

ArticleYear
Ultrastructure of intestinal lymphatics in Crohn's disease.
    American journal of clinical pathology, 1981, Volume: 76, Issue:4

    Topics: Adult; Aged; Cell Membrane Permeability; Crohn Disease; Female; Humans; Hypobetalipoproteinemias; Il

1981